Cards: collaborative atorvastatin diabetes study
principal researchers
Helen M Colhoun (University of Edinburgh)
data custodian
CARDS Executive Committee (including Pfizer representative)
funding
Pfizer Inc.; UK NHS R&D; Diabetes UK
key publications
- Design paper: Diab Med 2002; 19: 201–211
- Serum lipids, lipoproteins and NMR: Atherosclerosis 2003; 167: 243-55
- Baseline characteristics: Diab Med 2004; 21(8): 901-5
- Main results: Lancet 2004; 364: 685–96
- Effects in those aged 65-75 at randomization: Diabetes Care 2006; 29(11):2378-84
- Stroke: Diabet Med 2007; 24: 1313-21
- Safety and tolerability: Diab Vasc Dis Res 2008; 5(3): 177-83
- Kidney outcomes and CVD: Am J Kidney Dis 2009; 54(5):810-9
- Type 2 diabetes: Diabetologia 2009; 52: 218-25; Erratum in: Diabetologia 2009; 52: 556
- Targets of statin therapy: Clin Chem 2009; 55: 473-80
- Predictive biomarkers: Diabetes 2011; 60: 2379-85
- TNF-α and vascular adhesion molecules: Br J Diabetes Vasc Dis 2011; 11: 288-297
- Importance of Lp(a): J Lipid Res 2012; 53: 1000-11
- Adult-onset autoimmune diabetes: Diabetes Care 2014; 37: 1643-9
- C-reactive protein: Diabetologia 2015; 58: 1494-502
- Glycaemia progression: Diabetologia 2015 (Nov 17); doi: 10.1007/s00125-015-3802-6